Towards Minimizing Health Disparities in Knowledge of Genetic Variations for Very Important Pharmacogenes

• In: Poster Presentation
• At: Stockholm (Sweden) (2017)
• Type: Poster
• Poster code: P-A-053-Tuesday
• By: STRAKA, Robert (University of Minnesota, Experimental and Clinical Pharmacology, Eagan, United States)
• Co-author(s): Robert Straka: Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, United States
  Youssef Roman: Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, United States
  Jenny Xiong: Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, United States
  Kathleen Culhane-Pera: Medicine Department, West Side Community Health Services, Inc, St. Paul, United States
  
• Abstract:

  Backgrounds

  Knowledge of genetic variations within very important pharmacogenes (VIPs) can inform optimal drug selection. However, the clinical impact can be fully realized only if these findings are explored in all members of society. Gaps of knowledge regarding minor allele frequencies (MAFs) for VIPs in minority populations, limit the utility of ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login